The New Yorker @NewYorker
In the nearly 120 years since Alzheimer’s disease was first identified, no one has figured out how to slow its progression, let alone prevent it or reverse its damage—but a new clinical trial may indicate a breakthrough. https://t.co/cbwtAihCMk — PolitiTweet.org
